speb/financial-data huggingface dataset:
Financial ratios for IFR.V — annual report dated 2024-12-31
Total revenue: 0
Operating income: -342800.69930069934
Net income: -1459251.7482517483
Capital expenditures: 0
Operating cash flow: -232097.90209790212
Net tangible assets: -1103272.7272727273
Owner earnings: -1459251.7482517483
Buffett classification: The Gruesome
Stock price: 0.027972027972027975
Shares outstanding: 38085397
Book value: -1103272.7272727275
Market cap (USD): 1065325.7902097902
Debt to equity: -0.035247959028446824
Current ratio: 0.19714636108290587
Quick ratio: 0.19714636108290587
Interest coverage ratio: -72.83878157503716
Free cash flow (dilution-adjusted): -343517.48251748254
Buyback yield (%): 0
Retained earnings: -51885723.77622378
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IFR.V — quarterly report dated 2024-12-31
Total revenue: 0
Operating income: -199552.44755244756
Net income: -448318.1818181818
Capital expenditures: 0
Operating cash flow: -46258.74125874126
Net tangible assets: -1103272.7272727273
Owner earnings: -448318.1818181818
Buffett classification: The Gruesome
Stock price: 0.027972027972027975
Shares outstanding: 38085397
Book value: -1103272.7272727275
Market cap (USD): 1065325.7902097902
Debt to equity: -0.035247959028446824
Current ratio: 0.19714636108290587
Quick ratio: 0.19714636108290587
Interest coverage ratio: -150.58575197889184
Free cash flow (dilution-adjusted): -116363.63636363638
Buyback yield (%): 0
Retained earnings: -51885723.77622378
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IFR.V — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -23339.16083916084
Net income: -43601.39860139861
Capital expenditures: 0
Operating cash flow: -40430.069930069934
Net tangible assets: -1146874.1258741259
Owner earnings: -43601.39860139861
Buffett classification: The Gruesome
Stock price: 0.027972027972027975
Shares outstanding: 38085397
Book value: -1146874.1258741259
Market cap (USD): 1065325.7902097902
Debt to equity: -0.034243276037633455
Current ratio: 0.15763021505061814
Quick ratio: 0.15763021505061814
Interest coverage ratio: -16.856060606060606
Free cash flow (dilution-adjusted): -40430.069930069934
Buyback yield (%): 0
Retained earnings: -51929325.17482518
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IFR.V — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -38996.3503649635
Net income: -300835.76642335765
Capital expenditures: 0
Operating cash flow: -34003.64963503649
Net tangible assets: -1497937.9562043794
Owner earnings: -300835.76642335765
Buffett classification: The Gruesome
Stock price: 0.029197080291970802
Shares outstanding: 38085397
Book value: -1497937.9562043794
Market cap (USD): 1111982.3941605838
Debt to equity: -0.02763409553278838
Current ratio: 0.10260924704199889
Quick ratio: 0.10260924704199889
Interest coverage ratio: -30.70402298850575
Free cash flow (dilution-adjusted): -34003.64963503649
Buyback yield (%): 0
Retained earnings: -54504437.95620438
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IFR.V — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -18956.8345323741
Net income: -226665.4676258993
Capital expenditures: 0
Operating cash flow: -22147.48201438849
Net tangible assets: -1703050.3597122303
Owner earnings: -226665.4676258993
Buffett classification: The Gruesome
Stock price: 0.02877697841726619
Shares outstanding: 38085397
Book value: -1703050.3597122305
Market cap (USD): 1095982.6474820145
Debt to equity: -0.024188506446325676
Current ratio: 0.06198467082889193
Quick ratio: 0.06198467082889193
Interest coverage ratio: -17.804054054054053
Free cash flow (dilution-adjusted): -22147.48201438849
Buyback yield (%): 0
Retained earnings: -53946866.90647482
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IFR.V — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -45102.189781021894
Net income: -150204.3795620438
Capital expenditures: 0
Operating cash flow: -31638.686131386858
Net tangible assets: -1878116.7883211677
Owner earnings: -150204.3795620438
Buffett classification: The Gruesome
Stock price: 0.029197080291970802
Shares outstanding: 38085397
Book value: -1878116.7883211677
Market cap (USD): 1111982.3941605838
Debt to equity: -0.022467761618642685
Current ratio: 0.04017398343352427
Quick ratio: 0.04017398343352427
Interest coverage ratio: -44.61371841155235
Free cash flow (dilution-adjusted): -31638.686131386858
Buyback yield (%): 0
Retained earnings: -54884616.78832117
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IFR.V — annual report dated 2025-12-31
Total revenue: 0
Operating income: -127693.4306569343
Net income: -726525.5474452554
Capital expenditures: 0
Operating cash flow: -130313.86861313868
Net tangible assets: -1878116.7883211677
Owner earnings: -726525.5474452554
Buffett classification: The Gruesome
Stock price: 0.029197080291970802
Shares outstanding: 38085397
Book value: -1878116.7883211677
Market cap (USD): 1111982.3941605838
Debt to equity: -0.022467761618642685
Current ratio: 0.04017398343352427
Quick ratio: 0.04017398343352427
Interest coverage ratio: -26.566438876233867
Free cash flow (dilution-adjusted): -130313.86861313868
Buyback yield (%): 0
Retained earnings: -54884616.78832117
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IIF — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 16.44
Shares outstanding: 9443167
Market cap (USD): 155245665.48000002
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IIF — annual report dated 2022-12-31
Total revenue: -35563000
Net income: -36245000
Capital expenditures: 0
Net tangible assets: 258488000
Owner earnings: -36245000
Return on net tangible assets (%): -14.021927516944693
Buffett classification: The Gruesome
Stock price: 14.87
Shares outstanding: 9443167
Book value: 258488000
P/B ratio: 0.5432356368187304
Market cap (USD): 140419893.29
Debt to equity: 0
Buyback yield (%): 0
Retained earnings: 55962000
Receivables turnover: -1616.5
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IIF — annual report dated 2023-12-31
Total revenue: 49890000
Net income: 49288000
Capital expenditures: 0
Net tangible assets: 264889000
Owner earnings: 49288000
Return on net tangible assets (%): 18.607039174899676
Buffett classification: The Gruesome
Stock price: 18.06
P/E ratio: 3.460144376318779
Shares outstanding: 9443167
Book value: 264889000
P/B ratio: 0.6438304196097233
Market cap (USD): 170543596.01999998
Debt to equity: 0
COGS to revenue (%): 0
SG&A to revenue (%): 1.4351573461615554
Buyback yield (%): 0
Retained earnings: 74059000
Receivables turnover: 1133.8636363636363
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IIF — annual report dated 2024-12-31
Total revenue: 63073000
Net income: 62425000
Capital expenditures: 0
Net tangible assets: 293942000
Owner earnings: 62425000
Return on net tangible assets (%): 21.237182845595388
Buffett classification: The Gruesome
Stock price: 23.41
P/E ratio: 3.541282170124149
Shares outstanding: 9443167
Book value: 293942000
P/B ratio: 0.7520685695477339
Market cap (USD): 221064539.47
Debt to equity: 0
COGS to revenue (%): 0
SG&A to revenue (%): 1.239833209138617
Buyback yield (%): 0
Retained earnings: 110434000
Receivables turnover: 1433.4772727272727
Capitalized R&D asset: 0
Revenue growth (%): 26.42413309280417
Rule of 40 score: 26.42413309280417
Financial ratios for IIF — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 293942000
Buffett classification: The Gruesome
Stock price: 23.41
Shares outstanding: 9443167
Book value: 293942000
P/B ratio: 0.7520685695477339
Market cap (USD): 221064539.47
Debt to equity: 0
Buyback yield (%): 0
Retained earnings: 110434000
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IIF — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 297461000
Buffett classification: The Gruesome
Stock price: 26.15
Shares outstanding: 9443167
Book value: 297461000
P/B ratio: 0.8301552709430816
Market cap (USD): 246938817.04999998
Debt to equity: 0
Buyback yield (%): 0
Retained earnings: 116983000
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IRIS.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.3286298298826322
Shares outstanding: 20568247
Market cap (USD): 27327586.512593962
Buyback yield (%): 0
Retained earnings: -372622.9724383489
Capitalized R&D asset: 49874.71976790189
Rule of 40 score: 0
Financial ratios for IRIS.NS — annual report dated 2023-03-31
Total revenue: 8961169.305724727
Gross profit: 4269220.462850183
Operating income: 628562.7283800244
Net income: 521936.6626065774
Capital expenditures: 297710.1096224117
Operating cash flow: 695383.6784409258
Depreciation & amortization: 573447.0158343484
Net tangible assets: 3178014.616321559
Owner earnings: 797673.568818514
Return on net tangible assets (%): 25.099745127723587
Capex to operating income (%): 47.36362755546943
Buffett classification: The Good
Stock price: 0.8599269183922046
P/E ratio: 33.88761611631
Shares outstanding: 20568247
Book value: 3852947.6248477465
P/B ratio: 4.590560521865032
Market cap (USD): 17687189.259439707
Debt to equity: 0.18289934150420295
Current ratio: 1.663630727128899
Quick ratio: 1.663630727128899
Effective tax rate (%): 17.622745972547964
Interest coverage ratio: 7.462762111352133
COGS to revenue (%): 52.35866752207385
R&D to revenue (%): 1.1573822365273367
SG&A to revenue (%): 11.350909051367926
Free cash flow (dilution-adjusted): 341412.9110840439
Buyback yield (%): 0
Retained earnings: 176857.49086479904
Receivables turnover: 2.9622686331589905
Capitalized R&D asset: 137131.04397409232
ROCI (R&D-adjusted, %): 14.530459426380629
FCF margin (%): 3.8099147492497063
Rule of 40 score: 3.8099147492497063
Financial ratios for IRIS.NS — annual report dated 2024-03-31
Total revenue: 12267250.269816525
Gross profit: 6547715.553423672
Operating income: 1345341.168005756
Net income: 1053879.362033817
Capital expenditures: 464348.24319462763
Operating cash flow: 1402710.1570931766
Depreciation & amortization: 542259.2637006835
Net tangible assets: 4328480.633169445
Owner earnings: 1131790.382539873
Return on net tangible assets (%): 26.147521000022163
Capex to operating income (%): 34.51527792633793
Buffett classification: The Good
Stock price: 1.3747600767754318
P/E ratio: 26.830779540351894
Shares outstanding: 20568247
Book value: 4933721.069672622
P/B ratio: 5.731253231697659
Market cap (USD): 28276404.824856043
Debt to equity: 0.15850110470245954
Current ratio: 2.0697740553850426
Quick ratio: 2.0697740553850426
Effective tax rate (%): 13.940598713265896
Interest coverage ratio: 14.779080490054012
COGS to revenue (%): 46.624423490125764
SG&A to revenue (%): 9.244686529171057
Free cash flow (dilution-adjusted): 854622.8564576089
Buyback yield (%): 0
Retained earnings: 1216632.6897709558
Receivables turnover: 4.583920345575451
Capitalized R&D asset: 85947.69528223833
ROCI (R&D-adjusted, %): 22.120738819716106
Rosenberg metric: 21.968813498072038
FCF margin (%): 6.966702705661771
Revenue growth (%): 36.89341034969344
Rule of 40 score: 43.860113055355214
Financial ratios for IRIS.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 6213413.76015289
Buffett classification: The Gruesome
Stock price: 4.067725752508362
Shares outstanding: 20568247
Book value: 7204873.387482084
P/B ratio: 11.612416139222669
Market cap (USD): 83665988.00585285
Debt to equity: 0.07530438069470416
Current ratio: 2.303991459846467
Quick ratio: 2.303991459846467
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IRIS.NS — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 5.303648443874577
Shares outstanding: 20568247
Market cap (USD): 109086751.19477794
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IRIS.NS — quarterly report dated 2025-03-31
Total revenue: 3476700.958615852
Gross profit: 1770142.6233341126
Operating income: 590776.2450315641
Net income: 336883.32943652093
Capital expenditures: 0
Depreciation & amortization: 52279.635258358656
Net tangible assets: 7606967.500584521
Owner earnings: 389162.9646948796
Return on net tangible assets (%): 5.115875211310896
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 4.394328393044696
P/E ratio: 67.07339298922435
Shares outstanding: 20568247
Book value: 8896422.726209959
P/B ratio: 10.159547783287666
Market cap (USD): 90383631.78725639
Debt to equity: 0.056636005256241795
Current ratio: 2.4333254100309007
Quick ratio: 2.4333254100309007
Effective tax rate (%): 40.4754771513667
Interest coverage ratio: 24.857353664535168
COGS to revenue (%): 49.0855657589014
Buyback yield (%): 0
Retained earnings: 2709843.3481412204
Receivables turnover: 1.0060791610284168
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.066626650660265
Rule of 40 score: 0
Financial ratios for IRIS.NS — annual report dated 2025-03-31
Total revenue: 12822071.5454758
Gross profit: 7124152.443301379
Operating income: 1926584.0542436286
Net income: 1550151.9756838905
Capital expenditures: 835866.2613981762
Operating cash flow: 3207855.97381342
Depreciation & amortization: 178863.68950198736
Net tangible assets: 7606967.500584521
Owner earnings: 893149.4037877016
Return on net tangible assets (%): 11.74120178269556
Capex to operating income (%): 43.38592233009708
Buffett classification: The Good
Stock price: 4.394328393044696
P/E ratio: 58.30630364315167
Shares outstanding: 20568247
Book value: 8896422.726209959
P/B ratio: 10.159547783287666
Market cap (USD): 90383631.78725639
Debt to equity: 0.056636005256241795
Current ratio: 2.4333254100309007
Quick ratio: 2.4333254100309007
Effective tax rate (%): 28.74282733437663
Interest coverage ratio: 41.2
COGS to revenue (%): 44.438366156090446
SG&A to revenue (%): 7.2210065645514225
Free cash flow (dilution-adjusted): 2211830.72246902
Buyback yield (%): 0
Retained earnings: 2709843.3481412204
Receivables turnover: 3.71041948579161
Capitalized R&D asset: 34225.94397076736
ROCI (R&D-adjusted, %): 19.36085412928928
FCF margin (%): 17.25018234865062
Revenue growth (%): 4.522784352288041
Rule of 40 score: 21.77296670093866
Financial ratios for IRIS.NS — quarterly report dated 2025-06-30
Total revenue: 3493903.580622514
Gross profit: 1470126.3749122398
Operating income: -84191.43458928155
Net income: 26246.19705125205
Capital expenditures: 0
Depreciation & amortization: 85232.85747718232
Owner earnings: 111479.05452843437
Buffett classification: The Gruesome
Stock price: 3.5607301661596074
P/E ratio: 201.68554803650167
Shares outstanding: 20568247
Market cap (USD): 73237977.55792184
Effective tax rate (%): 30.75023155294844
Interest coverage ratio: -4.5595690747782
COGS to revenue (%): 57.92309830569779
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 0.49479728660673916
Rule of 40 score: 0.49479728660673916
Financial ratios for IRIS.NS — quarterly report dated 2025-09-30
Total revenue: 3220236.753100338
Gross profit: 1320281.848928974
Operating income: -40315.67080045096
Net income: 13173889.515219841
Capital expenditures: 0
Depreciation & amortization: 57147.68883878241
Net tangible assets: 20028703.494926717
Owner earnings: 13231037.204058623
Return on net tangible assets (%): 66.06037783429194
Buffett classification: The Gruesome
Stock price: 3.467305524239008
P/E ratio: 5.268249695689005
Shares outstanding: 20568247
Book value: 21320157.835400224
P/B ratio: 3.3450219739273166
Market cap (USD): 71316396.4470124
Debt to equity: 0.010858770936249734
Current ratio: 2.421760100923135
Quick ratio: 2.421760100923135
Effective tax rate (%): 12.283547202213423
Interest coverage ratio: -4.334545454545454
COGS to revenue (%): 59.000472631155155
Buyback yield (%): 0
Receivables turnover: 1.0948567967863603
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.18334568968434395
Revenue growth (%): -7.832695471047208
Rule of 40 score: -7.832695471047208
Financial ratios for IRIS.NS — quarterly report dated 2025-12-31
Total revenue: 3964386.7661802387
Gross profit: 1968285.6188036094
Operating income: 505592.0686198062
Net income: 591912.6657012366
Capital expenditures: 0
Depreciation & amortization: 59852.9575582043
Owner earnings: 651765.6232594409
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 3.403141361256545
P/E ratio: 4.954136203909627
Shares outstanding: 20568247
Market cap (USD): 69996652.09424084
Effective tax rate (%): 25.517241379310345
Interest coverage ratio: 21.479886417415997
COGS to revenue (%): 50.3508175439681
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 23.10854977862909
Rule of 40 score: 23.10854977862909
Financial ratios for JAY.AX — annual report dated 2021-06-30
Total revenue: 570984.962406015
Gross profit: 570984.962406015
Operating income: -3648196.2406015038
Net income: -3375064.661654135
Capital expenditures: 1572.9323308270675
Depreciation & amortization: 748141.3533834586
Net tangible assets: 12514.285714285714
Owner earnings: -2628496.2406015038
Return on net tangible assets (%): -21003.96539293439
Buffett classification: The Gruesome
Stock price: 0.18796992481203006
Shares outstanding: 1554555758
Book value: 1942669.1729323305
P/B ratio: 150.41661906144174
Market cap (USD): 292209728.9473684
Debt to equity: 0.7312015481373972
Current ratio: 1.0941626168999306
Quick ratio: 1.0941626168999306
Interest coverage ratio: -13.34659437870311
COGS to revenue (%): 0
SG&A to revenue (%): 360.78192280849606
Free cash flow (dilution-adjusted): -2371930.827067669
Buyback yield (%): 0.08391156079716505
Retained earnings: -22735955.639097743
Receivables turnover: 0.7732385991064192
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -184.8310994326428
FCF margin (%): -415.41038437734557
Rule of 40 score: -415.41038437734557
Financial ratios for JAY.AX — annual report dated 2022-06-30
Total revenue: 1765228.275862069
Gross profit: 1765228.275862069
Operating income: -3776972.413793104
Net income: -3516829.6551724137
Capital expenditures: 39544.8275862069
Depreciation & amortization: 837546.2068965518
Net tangible assets: 1789351.0344827587
Owner earnings: -2718828.275862069
Return on net tangible assets (%): -151.94493553625102
Buffett classification: The Gruesome
Stock price: 0.08965517241379312
Shares outstanding: 1554555758
Book value: 3720387.586206897
P/B ratio: 37.46221630968371
Market cap (USD): 139373964.51034483
Debt to equity: 0
Current ratio: 1.8243624251343034
Quick ratio: 1.8243624251343034
Interest coverage ratio: -34.56233907204524
COGS to revenue (%): 0
SG&A to revenue (%): 74.9436333524901
Free cash flow (dilution-adjusted): -3735415.1724137934
Buyback yield (%): 0.19992404603288405
Retained earnings: -23873467.586206898
Receivables turnover: 2.2350534710561223
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -100.2512592249808
FCF margin (%): -211.61088475027748
Revenue growth (%): 209.15495014505368
Rule of 40 score: -2.4559346052238027
Financial ratios for JAY.AX — annual report dated 2023-06-30
Total revenue: 3367828.476821192
Gross profit: 3367828.476821192
Operating income: -4202633.774834437
Net income: -5404113.907284768
Capital expenditures: 15845.033112582782
Depreciation & amortization: 920953.642384106
Net tangible assets: -224982.11920529802
Owner earnings: -4499005.298013245
Buffett classification: The Gruesome
Stock price: 0.0728476821192053
Shares outstanding: 1554555758
Book value: 1409353.6423841058
P/B ratio: 80.35299323723618
Market cap (USD): 113245783.69536424
Debt to equity: 0
Current ratio: 0.9465923553871814
Quick ratio: 0.9465923553871814
Interest coverage ratio: -60.1297826375334
COGS to revenue (%): 0
SG&A to revenue (%): 96.0774928958684
Free cash flow (dilution-adjusted): -3394892.715231788
Buyback yield (%): 0.18667829486873777
Retained earnings: -27673333.774834435
Receivables turnover: 3.798131638244654
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -284.82278626454416
FCF margin (%): -100.80361094981123
Revenue growth (%): 90.78713630827578
Rule of 40 score: -10.016474641535453
Financial ratios for JYOTHYLAB.NS — annual report dated 2022-03-31
Total revenue: 289476328.6298299
Gross profit: 119042951.33852038
Operating income: 25394487.669787683
Net income: 21360081.761835687
Capital expenditures: 2820058.024528551
Operating cash flow: 26712224.713174205
Depreciation & amortization: 7670737.175260452
Net tangible assets: 86153765.00065938
Owner earnings: 26210760.912567586
Return on net tangible assets (%): 30.423233288025177
Capex to operating income (%): 11.105000664705786
Buffett classification: The Great
Stock price: 1.820123961492813
P/E ratio: 31.290888205922574
Shares outstanding: 367214511
Book value: 185007846.4987472
P/B ratio: 3.6126896406174436
Market cap (USD): 668375930.4789662
Debt to equity: 0.12206082409156081
Current ratio: 1.3906303770709405
Quick ratio: 0.819842390369205
Effective tax rate (%): 19.190956391738023
Interest coverage ratio: 16.369682750178516
COGS to revenue (%): 58.876447030407284
SG&A to revenue (%): 14.372203713818832
Free cash flow (dilution-adjusted): 23276552.815508373
Buyback yield (%): 0
Retained earnings: 111202716.60292761
Inventory turnover: 4.348191041032049
Receivables turnover: 15.3413416883381
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.820226203961715
FCF margin (%): 8.040917516704257
Rule of 40 score: 8.040917516704257
Financial ratios for JYOTHYLAB.NS — annual report dated 2023-03-31
Total revenue: 302579780.75517666
Gross profit: 126500609.0133983
Operating income: 32550548.11205847
Net income: 29199756.394640684
Capital expenditures: 1482338.611449452
Operating cash flow: 40031668.69671133
Depreciation & amortization: 6105968.331303289
Net tangible assets: 92148599.26918393
Owner earnings: 33823386.114494525
Return on net tangible assets (%): 36.70526343616993
Capex to operating income (%): 4.553958988175422
Buffett classification: The Great
Stock price: 2.2087697929354446
P/E ratio: 27.77736596368414
Shares outstanding: 367214511
Book value: 188922046.2850183
P/B ratio: 4.293264525627155
Market cap (USD): 811092319.4243605
Debt to equity: 0.02999903291318784
Current ratio: 1.9077328214215397
Quick ratio: 1.164820830872219
Effective tax rate (%): 19.881692400240624
Interest coverage ratio: 20.509593246354566
COGS to revenue (%): 58.19264304518996
SG&A to revenue (%): 13.91606083295091
Free cash flow (dilution-adjusted): 35710109.6224117
Buyback yield (%): 0
Retained earnings: 115683313.03288673
Inventory turnover: 4.789008149473266
Receivables turnover: 18.026122922864815
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 16.14362778559735
FCF margin (%): 11.80188231126569
Revenue growth (%): 4.526605746096401
Rule of 40 score: 16.32848805736209
Financial ratios for JYOTHYLAB.NS — annual report dated 2024-03-31
Total revenue: 330371747.2118959
Gross profit: 160406523.5639765
Operating income: 51724427.389375225
Net income: 44303873.36611105
Capital expenditures: 1731622.4967022424
Operating cash flow: 54913059.11979853
Depreciation & amortization: 5991126.034296678
Net tangible assets: 121900707.51888716
Owner earnings: 48563376.903705485
Return on net tangible assets (%): 39.838470089421854
Capex to operating income (%): 3.3477847587693876
Buffett classification: The Great
Stock price: 5.094769673704414
P/E ratio: 42.228211942707155
Shares outstanding: 367214511
Book value: 217077587.24067634
P/B ratio: 8.618454710908216
Market cap (USD): 1870873354.386996
Debt to equity: 0.027930461106722426
Current ratio: 2.370666333707912
Quick ratio: 1.7807050401631501
Effective tax rate (%): 22.87611728343497
Interest coverage ratio: 91.19027484143763
COGS to revenue (%): 51.44665822132365
SG&A to revenue (%): 14.954064835551751
Free cash flow (dilution-adjusted): 50345365.151696846
Buyback yield (%): 0
Retained earnings: 144878282.76771796
Inventory turnover: 4.999435626102293
Receivables turnover: 13.679775559858978
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 22.460541869099504
FCF margin (%): 15.239004417470973
Revenue growth (%): 9.185004492817136
Rule of 40 score: 24.42400891028811
Financial ratios for JYOTHYLAB.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 130629479.21643575
Buffett classification: The Gruesome
Stock price: 6.481605351170568
Shares outstanding: 367214511
Book value: 225493311.0367893
P/B ratio: 10.55525562413141
Market cap (USD): 2380139539.5250835
Debt to equity: 0.02959482580528967
Current ratio: 2.4117726709996905
Quick ratio: 1.8234873104302072
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for JYOTHYLAB.NS — quarterly report dated 2024-12-31
Total revenue: 82027042.77887864
Gross profit: 40838093.017834246
Operating income: 11830050.122391887
Net income: 10188833.197342347
Capital expenditures: 0
Depreciation & amortization: 1664529.665462175
Owner earnings: 11853362.862804523
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 4.501340482573727
P/E ratio: 40.558067644683106
Shares outstanding: 367214511
Market cap (USD): 1652957544.152815
Effective tax rate (%): 23.210050074672758
Interest coverage ratio: 68.57432432432434
COGS to revenue (%): 50.2138665075102
SG&A to revenue (%): 9.04918219152776
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for JYOTHYLAB.NS — annual report dated 2025-03-31
Total revenue: 332243394.90296936
Gross profit: 164675005.8452186
Operating income: 52299509.001636654
Net income: 43391395.83820435
Capital expenditures: 6757072.714519522
Operating cash flow: 36416880.99134907
Depreciation & amortization: 6560673.369184007
Net tangible assets: 148597147.53331774
Owner earnings: 43194996.49286883
Return on net tangible assets (%): 29.068523326252855
Capex to operating income (%): 12.919954400160941
Buffett classification: The Great
Stock price: 3.7303069202940833
P/E ratio: 31.568996690575112
Shares outstanding: 367214511
Book value: 161633154.07996255
P/B ratio: 8.4748877135568
Market cap (USD): 1369822831.6157079
Debt to equity: 0.04432197076543639
Current ratio: 2.763337705816708
Quick ratio: 2.121072106819116
Effective tax rate (%): 24.18139107343479
Interest coverage ratio: 75.44182124789207
COGS to revenue (%): 50.43543126167748
SG&A to revenue (%): 15.376793185104908
Free cash flow (dilution-adjusted): 29572129.99766191
Buyback yield (%): 0
Retained earnings: 83249941.54781388
Inventory turnover: 4.369394909312605
Receivables turnover: 10.35566972744498
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 29.566257575457172
FCF margin (%): 8.900742784156284
Revenue growth (%): 0.5665277696621643
Rule of 40 score: 9.467270553818448
Financial ratios for JYOTHYLAB.NS — quarterly report dated 2025-03-31
Total revenue: 77747252.74725275
Gross profit: 36276595.74468085
Operating income: 11813186.813186813
Net income: 8919803.600654664
Capital expenditures: 0
Depreciation & amortization: 1700958.6158522328
Net tangible assets: 148597147.53331774
Owner earnings: 10620762.216506897
Return on net tangible assets (%): 7.147352686649358
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 3.7303069202940833
P/E ratio: 38.3927408310641
Shares outstanding: 367214511
Book value: 161633154.07996255
P/B ratio: 8.4748877135568
Market cap (USD): 1369822831.6157079
Debt to equity: 0.04432197076543639
Current ratio: 2.763337705816708
Quick ratio: 2.121072106819116
Effective tax rate (%): 28.65962024132448
Interest coverage ratio: 60.87349397590362
COGS to revenue (%): 53.34035034959778
SG&A to revenue (%): 37.711450266897224
Buyback yield (%): 0
Retained earnings: 83249941.54781388
Inventory turnover: 1.0813595488492609
Receivables turnover: 2.4232983530097654
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.678298339182215
Revenue growth (%): -5.217535445186025
Rule of 40 score: -5.217535445186025
Financial ratios for JYOTHYLAB.NS — quarterly report dated 2025-06-30
Total revenue: 87901942.42920665
Gross profit: 42216241.51649895
Operating income: 12804820.968874328
Net income: 11325766.440439973
Capital expenditures: 0
Depreciation & amortization: 1722443.2483033
Owner earnings: 13048209.688743273
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 3.9389187924175055
P/E ratio: 47.52608838406745
Shares outstanding: 367214511
Market cap (USD): 1446428138.2263048
Effective tax rate (%): 24.104132361013097
Interest coverage ratio: 81.66417910447761
COGS to revenue (%): 51.973482781113134
SG&A to revenue (%): 7.836690139907615
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 13.061155633325875
Rule of 40 score: 13.061155633325875
Financial ratios for JYOTHYLAB.NS — quarterly report dated 2025-09-30
Total revenue: 82983089.06426156
Gross profit: 39874859.07553551
Operating income: 11620067.643742952
Net income: 9894024.80270575
Capital expenditures: 0
Depreciation & amortization: 1713641.488162345
Net tangible assets: 149582863.58511838
Owner earnings: 11607666.290868094
Return on net tangible assets (%): 7.760024118179077
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 3.4919954904171364
P/E ratio: 31.796712113835195
Shares outstanding: 367214511
Book value: 162111612.17587373
P/B ratio: 7.910052828520164
Market cap (USD): 1282311416.427734
Debt to equity: 0.037373168373982045
Current ratio: 2.792928184876408
Quick ratio: 2.179354980254498
Effective tax rate (%): 26.059482685988712
Interest coverage ratio: 75.78676470588235
COGS to revenue (%): 51.94821074368937
SG&A to revenue (%): 8.351221367823275
Buyback yield (%): 0
Inventory turnover: 1.139362336114422
Receivables turnover: 2.1777567383650407
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.544085434378194
Revenue growth (%): -5.595841489972287
Rule of 40 score: -5.595841489972287
Financial ratios for JYOTHYLAB.NS — quarterly report dated 2025-12-31
Total revenue: 82389439.67918013
Gross profit: 38320151.498273365
Operating income: 10602651.219783893
Net income: 9036426.423081208
Capital expenditures: 0
Depreciation & amortization: 1727748.6910994765
Owner earnings: 10764175.114180684
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 3.0935724629609
P/E ratio: 28.997449523788205
Shares outstanding: 367214511
Market cap (USD): 1136004699.2292523
Effective tax rate (%): 25.890736342042757
Interest coverage ratio: 88.95327102803739
COGS to revenue (%): 53.489000959965395
SG&A to revenue (%): 7.679723097308042
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -0.7153859801744753
Rule of 40 score: -0.7153859801744753
Financial ratios for KALPATARU.NS — quarterly report dated 2025-09-30
Total revenue: 89489289.74069898
Gross profit: 18303269.4475761
Operating income: -455467.8692220969
Net income: 559188.2750845547
Capital expenditures: 0
Depreciation & amortization: 1209695.603156708
Net tangible assets: 448245772.26606536
Owner earnings: 1768883.8782412626
Return on net tangible assets (%): 0.394623661322857
Buffett classification: The Gruesome
Stock price: 4.213077790304396
P/E ratio: 387.8683777928427
Shares outstanding: 205922093
Book value: 445299887.2604284
P/B ratio: 1.9482731107091222
Market cap (USD): 867565796.5512964
Debt to equity: 2.2602910013393047
Current ratio: 1.579715741549381
Quick ratio: 0.23308935506165807
Effective tax rate (%): -3.765690376569037
Interest coverage ratio: -0.3265966046887631
COGS to revenue (%): 79.54697204479888
Buyback yield (%): 0
Inventory turnover: 0.046428180145044864
Receivables turnover: 0.9765390482751832
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.05561383077427116
Revenue growth (%): 28.2487911208181
Rule of 40 score: 28.2487911208181
Financial ratios for KALPATARU.NS — quarterly report dated 2025-12-31
Total revenue: 56245961.90264008
Gross profit: 6301659.797259664
Operating income: -9676952.211206418
Net income: -6993427.6484348895
Capital expenditures: 0
Depreciation & amortization: 1361256.5445026178
Owner earnings: -5632171.103932272
Buffett classification: The Gruesome
Stock price: 3.74067060265122
Shares outstanding: 205922093
Market cap (USD): 770286719.7215106
Interest coverage ratio: -5.849831649831651
COGS to revenue (%): 88.79624494969501
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -37.14782845453751
Rule of 40 score: -37.14782845453751
Financial ratios for KSHINTL.NS — quarterly report dated 2025-12-31
Total revenue: 91096023.17032416
Gross profit: 9242731.424752144
Operating income: 4716609.11217556
Net income: 2598418.179792804
Capital expenditures: 0
Depreciation & amortization: 783001.0025621032
Owner earnings: 3381419.1823549075
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 3.983513423192604
P/E ratio: 25.93016663982674
Shares outstanding: 67755700
Market cap (USD): 269905740.4478111
Effective tax rate (%): 25.18922386144965
Interest coverage ratio: 2.9748471861167705
COGS to revenue (%): 89.8538584857093
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 47.02591184820299
Rule of 40 score: 47.02591184820299
Financial ratios for KWM — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: -55492464000
Buffett classification: The Gruesome
Stock price: 3.38
Shares outstanding: 68476338
Book value: 133605047000
P/B ratio: 0.0017323449049046777
Market cap (USD): 231450022.44
Debt to equity: 0.1906288465285297
Current ratio: 0.28936501671809733
Quick ratio: 0.26611348816243113
Buyback yield (%): 0
Retained earnings: -3389033000
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LRK.AX — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.4285714285714284
Shares outstanding: 107387335
Market cap (USD): 260797813.57142854
Buyback yield (%): 0.11707597343937962
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LRK.AX — annual report dated 2022-06-30
Total revenue: 16784761.379310347
Gross profit: 8948678.620689655
Operating income: -54852.41379310345
Net income: -324412.4137931035
Capital expenditures: 1496806.8965517243
Depreciation & amortization: 583159.3103448276
Net tangible assets: 60794139.31034483
Owner earnings: -1238060.0000000002
Return on net tangible assets (%): -2.0364791969171443
Buffett classification: The Gruesome
Stock price: 1.896551724137931
Shares outstanding: 107387335
Book value: 75002708.96551724
P/B ratio: 2.71544372401887
Market cap (USD): 203665635.3448276
Debt to equity: 0.06138356676183687
Current ratio: 7.359980194356401
Quick ratio: 3.676129222808802
Effective tax rate (%): 4331.339390123235
Interest coverage ratio: -0.2436219840538115
COGS to revenue (%): 46.68569651684056
SG&A to revenue (%): 44.7229761445357
Free cash flow (dilution-adjusted): -6873660
Buyback yield (%): 0.6449109918527425
Retained earnings: -6670015.172413793
Inventory turnover: 0.5561518663969163
Receivables turnover: 5.921014551282738
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.06913523448506108
FCF margin (%): -40.95178861745859
Rule of 40 score: -40.95178861745859
Financial ratios for LRK.AX — annual report dated 2023-06-30
Total revenue: 13163878.80794702
Gross profit: 6883505.298013245
Operating income: -4250184.105960265
Net income: -3250350.331125828
Capital expenditures: 397956.2913907285
Depreciation & amortization: 853537.7483443709
Net tangible assets: 55256888.74172185
Owner earnings: -2794768.874172186
Return on net tangible assets (%): -5.057774583066579
Buffett classification: The Gruesome
Stock price: 0.8741721854304636
Shares outstanding: 107387335
Book value: 69322213.90728477
P/B ratio: 1.3541838327618443
Market cap (USD): 93875021.32450332
Debt to equity: 0.04381376064358564
Current ratio: 3.5163013751632213
Quick ratio: 1.2904033353755402
Interest coverage ratio: -23.964906515707675
COGS to revenue (%): 47.709141063668255
SG&A to revenue (%): 73.41975384476999
Free cash flow (dilution-adjusted): -4149417.880794702
Buyback yield (%): 0
Retained earnings: -9655331.78807947
Inventory turnover: 0.5929636678475463
Receivables turnover: 9.963642588292023
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -5.890432657423954
FCF margin (%): -31.521240367920306
Revenue growth (%): -21.572439962277873
Rule of 40 score: -53.09368033019818
Financial ratios for LRK.AX — annual report dated 2024-06-30
Total revenue: 11153839.333333334
Gross profit: 6256120.666666667
Operating income: -4246480
Net income: -3045276.6666666665
Capital expenditures: 266093.3333333333
Depreciation & amortization: 902443.3333333334
Net tangible assets: 53363927.333333336
Owner earnings: -2408926.6666666665
Return on net tangible assets (%): -4.514148015417805
Buffett classification: The Gruesome
Stock price: 0.5733333333333334
Shares outstanding: 107387335
Book value: 67575285.33333333
P/B ratio: 0.9111132632238091
Market cap (USD): 61568738.733333334
Debt to equity: 0.02160707117694943
Current ratio: 2.441414311816678
Quick ratio: 0.472841405277252
Interest coverage ratio: -23.771248586537492
COGS to revenue (%): 43.91060800050972
SG&A to revenue (%): 81.69522374926326
Free cash flow (dilution-adjusted): -3195214
Buyback yield (%): 0
Retained earnings: -12764977.333333334
Inventory turnover: 0.49729161204910605
Receivables turnover: 15.265360699638228
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -6.176828995825715
FCF margin (%): -28.64676372422793
Revenue growth (%): -15.269355665901655
Rule of 40 score: -43.91611939012959
Financial ratios for MAM.AX — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.3609022556390977
Shares outstanding: 131409173
Market cap (USD): 47425866.94736842
Buyback yield (%): 0.6236579466183841
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MAM.AX — annual report dated 2022-06-30
Total revenue: 15814646.896551725
Net income: 9889033.103448275
Capital expenditures: 0
Depreciation & amortization: 143381.37931034484
Net tangible assets: 12989737.931034483
Owner earnings: 10032414.48275862
Return on net tangible assets (%): 77.233386354852
Buffett classification: The Gruesome
Stock price: 0.3448275862068966
P/E ratio: 4.58219802249765
Shares outstanding: 131409173
Book value: 12989744.827586208
P/B ratio: 3.488406318406085
Market cap (USD): 45313507.93103448
Debt to equity: 0.010354162673684757
Effective tax rate (%): 20.825710580111835
COGS to revenue (%): 0
SG&A to revenue (%): 16.88980333290335
Free cash flow (dilution-adjusted): 9793026.206896553
Buyback yield (%): 0.25777652523541866
Retained earnings: 10883663.448275862
Receivables turnover: 16.010549775249988
Capitalized R&D asset: 0
FCF margin (%): 61.92377402388829
Rule of 40 score: 61.92377402388829
Financial ratios for MAM.AX — annual report dated 2023-06-30
Total revenue: 8066864.900662252
Net income: 4047848.344370861
Capital expenditures: 0
Depreciation & amortization: 158658.27814569537
Net tangible assets: 12912933.774834437
Owner earnings: 4206506.622516557
Return on net tangible assets (%): 32.575917261455096
Buffett classification: The Gruesome
Stock price: 0.33112582781456956
P/E ratio: 10.749654505353266
Shares outstanding: 131409173
Book value: 12912950.331125828
P/B ratio: 3.3697156789310805
Market cap (USD): 43512971.19205298
Debt to equity: 0.028396668368502177
Effective tax rate (%): 23.5076150098127
COGS to revenue (%): 0
SG&A to revenue (%): 26.7162390897405
Free cash flow (dilution-adjusted): 3942545.695364238
Buyback yield (%): 0.19066248898773602
Retained earnings: 10841054.966887416
Receivables turnover: 8.828744634679865
Capitalized R&D asset: 0
FCF margin (%): 48.87333237774409
Revenue growth (%): -48.99117916808388
Rule of 40 score: -0.11784679033979018
Financial ratios for MAM.AX — annual report dated 2024-06-30
Total revenue: 8475901.333333334
Net income: 4235834.666666667
Capital expenditures: 0
Depreciation & amortization: 138150
Net tangible assets: 14000550.666666666
Owner earnings: 4373984.666666667
Return on net tangible assets (%): 31.241518785975376
Buffett classification: The Gruesome
Stock price: 0.3066666666666667
P/E ratio: 9.513783285844331
Shares outstanding: 131409173
Book value: 14056074
P/B ratio: 2.8670034785910588
Market cap (USD): 40298813.053333335
Debt to equity: 0.2502836851883392
Effective tax rate (%): 25.21655266865744
COGS to revenue (%): 0
SG&A to revenue (%): 24.38976794758976
Free cash flow (dilution-adjusted): 4101723.3333333335
Buyback yield (%): 0.5115882686846209
Retained earnings: 11985546.666666666
Receivables turnover: 7.803542876713758
Capitalized R&D asset: 0
FCF margin (%): 48.392768769055984
Revenue growth (%): 5.070574971913837
Rule of 40 score: 53.46334374096982
Financial ratios for MIRA — annual report dated 2023-12-31
Total revenue: 0
Operating income: -8526049
Net income: -11982343
Capital expenditures: 0
Operating cash flow: -4532403
Net tangible assets: 4374346
Owner earnings: -11982343
Return on net tangible assets (%): -273.9230733005574
Buffett classification: The Gruesome
Stock price: 1.05
Shares outstanding: 42022087
Book value: 4374346
P/B ratio: 10.086808713805448
Market cap (USD): 44123191.35
Debt to equity: 0.0011569729509279788
Current ratio: 8.704992142942894
Quick ratio: 8.704992142942894
Interest coverage ratio: -2.466818216274426
Free cash flow (dilution-adjusted): -7083349
Buyback yield (%): 0
Retained earnings: -21285062
Receivables turnover: 0
Capitalized R&D asset: 3148443.55
ROCI (R&D-adjusted, %): -109.81603670321117
Rule of 40 score: 0
Financial ratios for MIRA — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.3
Shares outstanding: 42022087
Market cap (USD): 54628713.1
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MIRA — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.14
Shares outstanding: 42022087
Market cap (USD): 47905179.17999999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MIRA — annual report dated 2024-12-31
Total revenue: 0
Operating income: -8018328
Net income: -7852659
Capital expenditures: 0
Operating cash flow: -5560606
Net tangible assets: 2199750
Owner earnings: -7852659
Return on net tangible assets (%): -356.9796113194681
Buffett classification: The Gruesome
Stock price: 1.14
Shares outstanding: 42022087
Book value: 2199750
P/B ratio: 21.777556167746333
Market cap (USD): 47905179.17999999
Debt to equity: 0
Current ratio: 3.9920702178339917
Quick ratio: 3.9920702178339917
Free cash flow (dilution-adjusted): -7481411
Buyback yield (%): 0
Retained earnings: -29137721
Capitalized R&D asset: 5135442.99
ROCI (R&D-adjusted, %): -97.10383457363766
Rule of 40 score: 0
Financial ratios for MIRA — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -1805200
Net income: -1783779
Capital expenditures: 0
Operating cash flow: -1630027
Net tangible assets: 1294165
Owner earnings: -1783779
Return on net tangible assets (%): -137.83242476809372
Buffett classification: The Gruesome
Stock price: 0.98
Shares outstanding: 42022087
Book value: 1294165
P/B ratio: 31.821016068275682
Market cap (USD): 41181645.26
Debt to equity: 0
Current ratio: 12.855424637148804
Quick ratio: 12.855424637148804
Free cash flow (dilution-adjusted): -2504839
Buyback yield (%): 0
Retained earnings: -30921500
Capitalized R&D asset: 314404
ROCI (R&D-adjusted, %): -99.1935896646854
Rule of 40 score: 0
Financial ratios for MIRA — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -1546100
Net income: -1537712
Capital expenditures: 0
Operating cash flow: -799651
Net tangible assets: 569859
Owner earnings: -1537712
Return on net tangible assets (%): -269.84078517668405
Buffett classification: The Gruesome
Stock price: 1.21
Shares outstanding: 42022087
Book value: 569859
P/B ratio: 89.22685308120079
Market cap (USD): 50846725.269999996
Debt to equity: 0
Current ratio: 2.7905977035371694
Quick ratio: 2.7905977035371694
Free cash flow (dilution-adjusted): -1289217
Buyback yield (%): 0
Retained earnings: -32459212
Capitalized R&D asset: 706847.68
ROCI (R&D-adjusted, %): -103.39910913079369
Rule of 40 score: 0
Financial ratios for MIRA — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -1316985
Net income: -1137673
Capital expenditures: 0
Operating cash flow: -1096954
Net tangible assets: 7549354
Owner earnings: -1137673
Return on net tangible assets (%): -15.069805972802442
Buffett classification: The Gruesome
Stock price: 1.36
Shares outstanding: 42022087
Book value: 7549354
P/B ratio: 7.570189226786822
Market cap (USD): 57150038.32000001
Debt to equity: 0
Current ratio: 90.53024092653051
Quick ratio: 90.53024092653051
Free cash flow (dilution-adjusted): -1487794
Buyback yield (%): 0
Retained earnings: -33596885
Capitalized R&D asset: 848844.31
ROCI (R&D-adjusted, %): -15.623501830199896
Rule of 40 score: 0
Financial ratios for MIRA — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -5824827
Net income: -5983321
Capital expenditures: 0
Operating cash flow: -1135037
Net tangible assets: 10391537
Owner earnings: -5983321
Return on net tangible assets (%): -57.578787430579325
Buffett classification: The Gruesome
Stock price: 1.51
Shares outstanding: 42022087
Book value: 10391537
P/B ratio: 6.10625274875122
Market cap (USD): 63453351.37
Debt to equity: 0
Current ratio: 15.750847496253924
Quick ratio: 15.750847496253924
Free cash flow (dilution-adjusted): -5692986
Buyback yield (%): 0
Retained earnings: -39580206
Capitalized R&D asset: 936756.14
ROCI (R&D-adjusted, %): -51.170494928300094
Rule of 40 score: 0
Financial ratios for MIRA — annual report dated 2025-12-31
Total revenue: 0
Operating income: -10493112
Net income: -10442485
Capital expenditures: 0
Operating cash flow: -4661669
Net tangible assets: 10391537
Owner earnings: -10442485
Return on net tangible assets (%): -100.49028358365082
Buffett classification: The Gruesome
Stock price: 1.51
Shares outstanding: 42022087
Book value: 10391537
P/B ratio: 6.10625274875122
Market cap (USD): 63453351.37
Debt to equity: 0
Current ratio: 15.750847496253924
Quick ratio: 15.750847496253924
Free cash flow (dilution-adjusted): -10974836
Buyback yield (%): 0
Retained earnings: -39580206
Capitalized R&D asset: 4453595.71
ROCI (R&D-adjusted, %): -73.91492696194292
Rule of 40 score: 0
Financial ratios for NCSM — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 28.99
Shares outstanding: 2624523
Market cap (USD): 76084921.77
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NCSM — annual report dated 2022-12-31
Total revenue: 155632000
Gross profit: 56085000
Operating income: -2253000
Net income: -952000
Capital expenditures: 602000
Operating cash flow: -1423000
Depreciation & amortization: 4319000
Net tangible assets: 70731000
Owner earnings: 2765000
Buffett classification: The Gruesome
Stock price: 25
Shares outstanding: 2624523
Book value: 109262000
P/B ratio: 0.6005113854771101
Market cap (USD): 65613075
Debt to equity: 0.11788178872801157
Current ratio: 4.954671338947606
Quick ratio: 2.861075001412988
Interest coverage ratio: -2.219704433497537
COGS to revenue (%): 63.963066721496865
SG&A to revenue (%): 37.48457900688804
Free cash flow (dilution-adjusted): -8593000
Buyback yield (%): 0.583725118812066
Retained earnings: -262464000
Inventory turnover: 2.687408887209114
Receivables turnover: 4.9294311415178
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.8634310952310058
FCF margin (%): -5.52135807546006
Rule of 40 score: -5.52135807546006